NEJM This Week Podcast Por NEJM Group capa

NEJM This Week

NEJM This Week

De: NEJM Group
Ouça grátis

OFERTA POR TEMPO LIMITADO: Apenas R$ 0,99/mês nos primeiros 3 meses

Renova automaticamente por R$ 19,90/mês após 3 meses

Sobre este título

Concise summaries of everything published in the latest weekly issue of the New England Journal of Medicine (NEJM). NEJM publishes new medical research findings, review articles, and editorial opinion on topics of importance to biomedical science and clinical practice.Copyright 2026 Massachusetts Medical Society Doença Física Higiene e Vida Saudável
Episódios
  • NEJM This Week — April 2, 2026
    Apr 1 2026
    This week, we present new research on treatment for muscle-invasive bladder cancer, left atrial appendage closure versus medical therapy for atrial fibrillation, gene-editing approaches for sickle cell disease and β-thalassemia, and the safety of discontinuing beta-blockers after myocardial infarction. We also review GLP-1 receptor agonists and discuss a Clinical Problem-Solving case of a man with progressive confusion. Perspectives explore corporatization; biologic, as opposed to chronologic, aging; and a legal case that could affect mental-health policy.
    Exibir mais Exibir menos
    27 minutos
  • NEJM This Week — April 9, 2026
    Apr 8 2026
    This week, we present new research on intensive LDL cholesterol targets, team-based strategies to improve blood pressure control, emerging therapies for immune and oncologic diseases, and a next-generation yellow fever vaccine. We review celiac disease and follow a compelling case of post-procedural complications. Perspectives explore health disparities and efforts to strengthen care in vulnerable communities.
    Exibir mais Exibir menos
    27 minutos
  • NEJM This Week — March 26, 2026
    Mar 25 2026
    This week, we present new clinical trials on immunotherapy for stage III mismatch repair–deficient colon cancer, early surgery for asymptomatic aortic stenosis, an approach to dengue virus suppression, and advances in gene and prime-editing therapies for rare disorders. We also review minipuberty. We follow the case of a 12-year-old girl with altered mental status and persistent hypoglycemia, and we explore Perspectives on corporate influences on health, vaccine communication, antitrust policy, conflicts of interest, and the meaning of the number needed to treat.
    Exibir mais Exibir menos
    28 minutos
Ainda não há avaliações